Verition Fund Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,375
| Closed | -$729K | – | 2648 |
|
|
2024
Q4 | $729K | Buy |
29,375
+14,351
| +96% | +$356K | ﹤0.01% | 1678 |
|
|
2024
Q3 | $368K | Buy |
+15,024
| New | +$368K | ﹤0.01% | 1859 |
|
|
2024
Q2 | – | Sell |
-7,894
| Closed | -$261K | – | 2332 |
|
|
2024
Q1 | $261K | Buy |
+7,894
| New | +$261K | ﹤0.01% | 1773 |
|
|
2022
Q4 | – | Sell |
-6,874
| Closed | -$327K | – | 1723 |
|
|
2022
Q3 | $327K | Sell |
6,874
-1,429
| -17% | -$68K | ﹤0.01% | 1677 |
|
|
2022
Q2 | $321K | Sell |
8,303
-4,521
| -35% | -$175K | 0.01% | 1640 |
|
|
2022
Q1 | $735K | Buy |
12,824
+6,471
| +102% | +$371K | 0.01% | 1099 |
|
|
2021
Q4 | $506K | Buy |
6,353
+2,472
| +64% | +$197K | ﹤0.01% | 1176 |
|
|
2021
Q3 | $338K | Sell |
3,881
-2,400
| -38% | -$209K | ﹤0.01% | 1171 |
|
|
2021
Q2 | $808K | Buy |
+6,281
| New | +$808K | 0.01% | 778 |
|